Comments
Loading...

Enlivex Therapeutics

ENLVNASDAQ
Logo brought to you by Benzinga Data

Enlivex Therapeutics (NASDAQ:ENLV) Stock Quotes, Forecast and News Summary

Enlivex Therapeutics Stock (NASDAQ: ENLV) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
0
0
0
0
Jun
0
0
0
0
Aug
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$1.16
Close-
Volume / Avg.17.05K / 119.44K
Day Range$1.15 - $1.17
52 Wk Range1.13 - 4.59
Market Cap$24.79M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
26
Short Interest
0.79%
Days to Cover1

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ENLV

FAQ

Q

How do I buy Enlivex Therapeutics (ENLV) stock?

A

You can purchase shares of Enlivex Therapeutics (NASDAQ:ENLV) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Enlivex Therapeutics (ENLV) competitors?

A

There are no as such competitors for Enlivex Therapeutics.

Q

What is the forecast, or price target, for Enlivex Therapeutics (ENLV) stock?

A

Enlivex Therapeutics has a consensus price target of $9.50.

Q

What is the current price for Enlivex Therapeutics (ENLV)?

A

The stock price for Enlivex Therapeutics (NASDAQ: ENLV) is $1.17 last updated November 14, 2024 at 9:29 AM EST.

Q

Does Enlivex Therapeutics (ENLV) pay a dividend?

A

There are no upcoming dividends for Enlivex Therapeutics.

Q

When is Enlivex Therapeutics (NASDAQ:ENLV) reporting earnings?

A

Enlivex Therapeutics’s Q2 earnings are confirmed for Saturday, November 30, 2024.

Q

Is Enlivex Therapeutics (ENLV) going to split?

A

There is no upcoming split for Enlivex Therapeutics.

Q

What sector and industry does Enlivex Therapeutics (ENLV) operate in?

A

Enlivex Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.